KINE-101

N/A

Report date: 2026/01/08 20:00:10

Base Information

Drug NameKINE-101
Drug Alias NameKINE-101
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionImmunosuppressantsT lymphocytes stimulants
TargetsUpdating
Therapy Area/IndicationsPolyradiculoneuropathy, Chronic Inflammatory DemyelinatingArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesKine Sciences Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPolyradiculoneuropathy, Chronic Inflammatory DemyelinatingArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A